- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06725147
Elomia - Digital Mental Health and Well-Being
Digital Mental Health and Well-Being
Study Overview
Status
Intervention / Treatment
Detailed Description
Elomia is a generative AI program that can respond to text users type in with unique responses that are designed to address therapeutic targets like stress, anxiety, procrastination, feeling overwhelmed and so on. Elomia was "trained" by real therapists with expertise in cognitive-behavioral therapy who responded to many different real people typing about their concerns. Thus, Elomia can suggest a number of different evidence based therapeutic strategies and can help the user process negative feelings, think through problems, plan solutions, and trouble shoot things that might get in the way of implementing those strategies. Elomia's arsenal includes:
- exercises for calming;
- exercises for falling asleep;
- grounding techniques;
- exercises to reduce anxiety;
- breathing exercises;
- exercises to improve self-esteem. The algorithm determines the user's need for one or another type of help while communicating with the chatbot and suggests an exercise to ease their emotional state. Elomia is not a substitute for professional care, and will detect when a person needs something more than a chatbot and will suggest connecting with other resources. More information about Elomia can be found via this website: https://elomia.com/
The ultimate goal of this study is to explore whether a mental health chatbot is acceptable and can improve symptoms of depression, anxiety, stress, and promote general psychological well-being in college students. The investigators will compare Elomia to a curated collection of digital wellness resources that are typically provided to students at our University.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Undergraduate student at the University of Pennsylvania.
- At least 18 years of age.
Exclusion Criteria:
* Severe depression or suicidality as indicated by Beck Depression Inventory score of >= 30, and/or a score of 2 or 3 on the Item (the suicide item) of the Beck Depression Inventory
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Elomia - Digital Mental Health Chatbot
Participants randomized to Elomia will be expected to use the intervention at least once per week (for around 30 minutes) but are encouraged to use as needed/wanted.
Elomia is a generative AI program that can respond to text the user types in with unique responses that are designed to address therapeutic targets like stress, anxiety, procrastination, feeling overwhelmed and so on.
Elomia was "trained" by real therapists with expertise in cognitive-behavioral therapy who responded to many different real people typing about their concerns.
Thus, Elomia can suggest a number of different evidence based therapeutic strategies and can help the user process negative feelings, think through problems, plan solutions, and trouble shoot things that might get in the way of implementing those strategies.
|
Elomia uses generative AI to respond to user input about psychological stress and distress.
It was trained on the responses of real therapists with expertise in cognitive-behavioral therapy.
It provides an array of wellness interventions including exercises for calming; • exercises for falling asleep; • grounding techniques; • exercises to reduce anxiety; • breathing exercises; • exercises to improve self-esteem.
|
|
Active Comparator: Penn Wellness Modules
Participants randomized to the control condition will be expected to use the intervention at least once per week (for around 30 minutes) but are encouraged to use as needed/wanted.
The control condition consists of a curated collection of digital wellness resources that are already available freely to Penn students, including tips on getting good sleep, learning center material on time management and procrastination, and so on.
The resources will be accessed via a single website, but there is no interactive component.
|
This active control intervention consists of a variety of digital wellness and stress management resources that are freely available to all Penn students.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Depression Inventory
Time Frame: Baseline and 4 week follow-up
|
Self-report inventory of depressive symptoms Scores range from 0 to 63.
Higher scores indicate more severe (worse) depressive symptoms.
|
Baseline and 4 week follow-up
|
|
GAD 7
Time Frame: Baseline and 4 week follow-up
|
Self-report inventory of symptoms of anxiety.
Scores range from 0 to 21.
Higher scores indicate more severe (worse) symptoms of anxiety.
|
Baseline and 4 week follow-up
|
|
Perceived Stress Scale
Time Frame: Baseline and 4 week follow-up
|
Self-report questionnaire of perceived stress.
Scores range from 0 to 40.
Higher scores indicate more severe (worse) perceived stress.
|
Baseline and 4 week follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Melissa G Hunt, PhD, University of Pennsylvania
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 857217
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perceived Stress
-
Istanbul Kent UniversityCompletedStress | Psychological | Perceived StressTurkey (Türkiye)
-
Mibelle AGCompleted
-
Vilnius UniversityLinkoeping UniversityCompleted
-
Pusan National University Yangsan HospitalCompletedPerceived StressKorea, Republic of
-
Ain Shams UniversityRecruitingPerceived StressEgypt
-
United States Naval Medical Center, San DiegoUniversity of California, San Francisco; TriService Nursing Research ProgramCompletedPerceived StressUnited States
-
Idaho State UniversityCompletedMusculoskeletal Disorders | Perceived Stress | Stress Management | Reported Stress | Perceived Pain | Reported PainUnited States
-
Radboud University Medical CenterWageningen University and Research; Movisie; Municipality of Meppel, the Netherlands and other collaboratorsCompletedPerceived Stress | Persistent PovertyNetherlands
-
Kutahya Health Sciences UniversityCompletedPsychological Resilience | Perceived Stress | Stress Management | Coping StrategyTurkey
-
The Cleveland ClinicGeneral ElectricCompletedHealthy Individuals With Perceived StressUnited States
Clinical Trials on AI enabled wellness chatbot
-
Taipei Medical UniversityNot yet recruitingCardiovascular Kidney Metabolic SyndromeTaiwan
-
Fudan UniversityNot yet recruiting
-
Wonkwang University HospitalCompletedMental Disease | Adherence to Care | Digital HealthSouth Korea
-
Montreal Heart InstituteWithdrawn
-
The University of Hong KongInnovation and Technology Commission, Hong KongEnrolling by invitationThyroid Cancer | Large Language ModelsHong Kong
-
Stockholm UniversityActive, not recruiting
-
Pakistan Council of Scientific and Industrial ResearchRecruitingDiabetes Mellitus, Type 2 | Diabetes | Diabetic RetinopathyPakistan
-
Kaiser PermanenteMassachusetts General Hospital; Stanford University; Cedars-Sinai Medical CenterNot yet recruitingCirrhosis | MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseUnited States
-
HeartFlow, Inc.Active, not recruitingAI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management (DECIDE)Coronary Artery DiseaseUnited States
-
The University of Hong KongCompletedTelephone Hotlines | AI ChatbotHong Kong